Bristol Myers Squibb (BMY) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.
- Bristol Myers Squibb's Income towards Parent Company rose 132894.74% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.1 billion, marking a year-over-year increase of 18672.57%. This contributed to the annual value of $7.1 billion for FY2025, which is 17898.8% up from last year.
- Per Bristol Myers Squibb's latest filing, its Income towards Parent Company stood at $1.1 billion for Q4 2025, which was up 132894.74% from $2.2 billion recorded in Q3 2025.
- Over the past 5 years, Bristol Myers Squibb's Income towards Parent Company peaked at $2.5 billion during Q1 2025, and registered a low of -$11.9 billion during Q1 2024.
- Over the past 5 years, Bristol Myers Squibb's median Income towards Parent Company value was $1.6 billion (recorded in 2022), while the average stood at $960.2 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first tumbled by 62527.57% in 2024, then skyrocketed by 132894.74% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Income towards Parent Company stood at $2.4 billion in 2021, then fell by 14.63% to $2.0 billion in 2022, then decreased by 12.99% to $1.8 billion in 2023, then tumbled by 95.69% to $76.0 million in 2024, then skyrocketed by 1328.95% to $1.1 billion in 2025.
- Its Income towards Parent Company was $1.1 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $1.3 billion in Q2 2025.